Pharmaceuticals, Biotechnology and Life Sciences
Vor expands expert governance and oversight with highly regarded physician-scientist and R&D leader CAMBRIDGE–(BUSINESS WIRE)–Vor Biopharma, an oncology company pioneering…
LONDON–(BUSINESS WIRE)–#Biotechnology–The research report on the global multiple sclerosis drugs market by Technavio predicts the market to post a CAGR…
SEATTLE & BASEL, Switzerland–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) and Lonza (SWX: LONN) today announced a long-term manufacturing agreement for commercial…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#DigitalDrugDesign–Exicure, Inc. (OTCQB: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
DUBLIN–(BUSINESS WIRE)–The “T-Cell Immunotherapies Market (4th Edition), 2019-2030” report has been added to ResearchAndMarkets.com’s offering. The T-Cell Immunotherapy Market, 2019-2030…
New Identity Reflects Commitment to Becoming a Leading Cell Therapy Company Company to Trade on NYSE American Under Ticker “LCTX”…
Administration of AXA2678 was well-tolerated with no significant safety issues over 28 days AXA2678 attenuated muscle mass loss and reduced…
Ahlers to lead commercial initiatives as lead product candidate VT-1161 moves rapidly through clinical development as a potential first FDA-approved…
TAKOMA PARK, Md.–(BUSINESS WIRE)–#Cold_Atmospheric_Plasma—US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC and…
The report, published today, analyses stock and market performance, M&A and the financing landscape during the first half of 2019…